OPS
AGIO icon

Orion Portfolio Solutions’s Agios Pharmaceuticals AGIO Stock Holding History

Orion Portfolio Solutions’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-121
Closed -$6K – 468
2020
Q2 		$6K Sell
121
-33
-21% -$1.53K ﹤0.01% 1375
2020
Q1 		$5K Buy
154
+13
+9% +$601 ﹤0.01% 1267
2019
Q4 		$7K Buy
+141
New +$5.33K ﹤0.01% 1122

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Orion Portfolio Solutions's AGIO Position: Q3 2020 in Review

Orion Portfolio Solutions sold out of Agios Pharmaceuticals (AGIO) in Q3 2020, closing a stake of 121 shares — an estimated $6K sold.

Orion Portfolio Solutions first reported a position in AGIO in Q4 2019 and held it in 3 quarters. The position peaked at $7K in Q4 2019. 214 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

  • Orion Portfolio Solutions reported no remaining Agios Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 121 Agios Pharmaceuticals shares in Q3 2020, an estimated $6K.
  • Orion Portfolio Solutions first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Orion Portfolio Solutions's Agios Pharmaceuticals position peaked at $7K in Q4 2019.
  • 214 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on Orion Portfolio Solutions's 13F filing for Q3 2020, filed 13 Nov 2020.